About limflow

This author has not yet filled in any details.
So far limflow has created 3 blog entries.

Limflow Receives FDA Approval for U.S. Pivotal Study of Minimally-Invasive Technology Designed to Prevent Amputations in Chronic Limb-Threatening Ischemia Patients

PARIS - September 19, 2019 — LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease (PAD), announced today that the U.S. Food and Drug Administration (FDA) has approved its Investigational Device Exemption for the PROMISE II pivotal study of the LimFlow Percutaneous Deep [...]

By | 2019-11-05T19:00:27+00:00 November 5th, 2019|

LimFlow Announces Presentation of the LimFlow Procedure at a Dedicated Symposium During the Leipzig Interventional Course, LINC 2015 – January 27-30, 2015

Dresden Germany 15 December 2014 -- LimFlow today announced that Drs. Andrej Schmidt and Jihad Mustapha will be chairing a session on the LimFlow procedure for treating Critical Limb Ischemia at the upcoming Leipzig Interventional Course or LINC on Tuesday 27 January 2015 starting at 16:00 CET (www.leipzig-interventional-course.com) . Download a schedule of the talks. About [...]

By | 2017-08-28T23:19:59+00:00 December 15th, 2014|

LimFlow Announces the Closing of Series A Financing

Dresden Germany 30 September, 2014 -- LimFlow today announced that it has closed its Series A financing with a major Family Fund leading the round. The terms and amount were not discussed. About LimFlow GmbH LimFlow is a private, venture-backed medical device company offering a novel therapeutic to treating Critical Limb Ischemia. LimFlow is enrolling [...]

By | 2017-08-28T23:25:13+00:00 September 30th, 2014|